Cambrian Solvents Limited 01203074 false 2025-05-01 2026-04-30 2026-04-30 The principal activity of the company is Manufacture of other chemical products Digita Accounts Production Advanced 6.30.9574.0 true 01203074 2025-05-01 2026-04-30 01203074 2026-04-30 01203074 core:RetainedEarningsAccumulatedLosses 2026-04-30 01203074 core:RevaluationReserve 2026-04-30 01203074 core:ShareCapital 2026-04-30 01203074 core:CurrentFinancialInstruments 2026-04-30 01203074 core:CurrentFinancialInstruments core:WithinOneYear 2026-04-30 01203074 core:LandBuildings core:OwnedOrFreeholdAssets 2026-04-30 01203074 core:PlantMachinery 2026-04-30 01203074 bus:SmallEntities 2025-05-01 2026-04-30 01203074 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 01203074 bus:FilletedAccounts 2025-05-01 2026-04-30 01203074 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 01203074 bus:RegisteredOffice 2025-05-01 2026-04-30 01203074 bus:Director1 2025-05-01 2026-04-30 01203074 bus:Director2 2025-05-01 2026-04-30 01203074 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 01203074 bus:Agent1 2025-05-01 2026-04-30 01203074 core:LandBuildings core:OwnedOrFreeholdAssets 2025-05-01 2026-04-30 01203074 core:PlantMachinery 2025-05-01 2026-04-30 01203074 countries:EnglandWales 2025-05-01 2026-04-30 01203074 2025-04-30 01203074 core:LandBuildings core:OwnedOrFreeholdAssets 2025-04-30 01203074 core:PlantMachinery 2025-04-30 01203074 2024-05-01 2025-04-30 01203074 2025-04-30 01203074 core:RetainedEarningsAccumulatedLosses 2025-04-30 01203074 core:RevaluationReserve 2025-04-30 01203074 core:ShareCapital 2025-04-30 01203074 core:CurrentFinancialInstruments 2025-04-30 01203074 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 01203074 core:LandBuildings core:OwnedOrFreeholdAssets 2025-04-30 01203074 core:PlantMachinery 2025-04-30 iso4217:GBP xbrli:pure

Cambrian Solvents Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2026

 

Cambrian Solvents Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Cambrian Solvents Limited

Company Information

Directors

I M Yarlott

J P Hextall

Registered Office

Unit K
Mochdre Industrial Estate
Mochdre
Newtown
SY16 4LE

Registered Number

01203074

Accountants

Verinder Powell Associates Limited Suite 5 Corum 2
Corum Office Park
Crown Way
Warmley
Bristol
BS30 8FJ

 

Cambrian Solvents Limited

(Registration number: 01203074)
Balance Sheet as at 30 April 2026

Note

2026
£

2025
£

Fixed assets

 

Tangible assets

4

477,888

482,309

Current assets

 

Stocks

204,265

213,583

Debtors

5

447,194

368,867

Cash at bank and in hand

 

1,212,709

706,058

 

1,864,168

1,288,508

Creditors: Amounts falling due within one year

6

(634,013)

(571,485)

Net current assets

 

1,230,155

717,023

Total assets less current liabilities

 

1,708,043

1,199,332

Provisions for liabilities

(82,327)

(84,065)

Net assets

 

1,625,716

1,115,267

Capital and reserves

 

Called up share capital

6,200

6,200

Revaluation reserve

431,098

431,098

Retained earnings

1,188,418

677,969

Shareholders' funds

 

1,625,716

1,115,267

 

Cambrian Solvents Limited

(Registration number: 01203074)
Balance Sheet as at 30 April 2026

For the financial year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 7 August 2026 and signed on its behalf by:
 

.........................................
I M Yarlott
Director

 

Cambrian Solvents Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2026

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit K
Mochdre Industrial Estate
Mochdre
Newtown
SY16 4LE

These financial statements were authorised for issue by the Board on 7 August 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).There have been no material departures from the Financial Reporting Standard 102 1A.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. The financial statements are prepared in Pounds Sterling (£), and are rounded to the nearest pound.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity;
- and specific criteria have been met for each of the company's activities.

 

Cambrian Solvents Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2026

Tangible assets

Tangible assets, excluding freehold property, are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Freehold property is shown at its most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in other comprehensive income.

Depreciation

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:

Asset class

Depreciation method and rate

Plant and machinery

- 25% on cost

Government grants

Government grants have been recognised on an accruals basis and have been recognised in the same period in which the related expense has been incurred.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell, which is equivalent to net realisable value.

The cost of finished goods and work in progress comprises all costs of purchase, direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired , the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used.

 

Cambrian Solvents Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2026

Research and development

Expenditure on research and development is written off in the year in which it is incurred. The company has claimed research and development expenditure credit under the merged scheme and the related tax credit is recognised in other income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Cambrian Solvents Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2026

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2025 - 10).

4

Tangible assets

Freehold property
£

Plant and machinery
£

Total
£

Cost or valuation

At 1 May 2025

468,717

214,102

682,819

Additions

-

3,285

3,285

At 30 April 2026

468,717

217,387

686,104

Depreciation

At 1 May 2025

-

200,510

200,510

Charge for the year

-

7,706

7,706

At 30 April 2026

-

208,216

208,216

Carrying amount

At 30 April 2026

468,717

9,171

477,888

At 30 April 2025

468,717

13,592

482,309

The freehold property has been revalued in the year by the directors after considering the current market value of similar properties and confirm the value recognised aligns with the fair value of the property at 30 April 2026.

The historical cost value relating to the freehold property recognised under the revaluation model is £41,201 (2025 - £41,201).


 

 

Cambrian Solvents Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2026

5

Debtors

2026
£

2025
£

Trade debtors

402,561

309,916

Prepayments and accrued income

44,633

58,652

Other debtors

-

299

447,194

368,867

6

Creditors

Due within one year

2026
£

2025
£

Trade creditors

357,455

287,456

Taxation and social security

245,532

237,087

Accruals and deferred income

26,752

45,113

Other creditors

4,274

1,829

634,013

571,485

7

Pension commitments

Included in the balance sheet are pensions of £4,274 (2025 - £1,829). The company participates in a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

8

Other financial commitments

The company has a cross guarantee with Confederate Chemicals GRP Limited (Parent company) for all banking facilities utilised by either company, securing all amounts on the assets of the group.